Incidence and survival of adult central nervous system tumors in the Veneto region: a population-based registry study (2016–2020)
Authors:
- 15 October 2025
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 176 (1) , 1-9
Abstract
Purpose Central nervous system (CNS) tumors represent a heterogeneous group of neoplasms with significant clinical impact and variable prognosis. Despite the relatively low incidence, they account for considerable morbidity and mortality. In Italy, population-based data on incidence and survival by histological subtype and tumor grade remain limited, particularly for rarer CNS tumor entities. Methods We conducted a retrospective population-based study using data from the Veneto Cancer Registry, including adults diagnosed with CNS tumors between 2016 and 2020. A dedicated text-mining algorithm was applied to pathology reports to extract tumor grade. Tumors were categorized into six main histological groups. We estimated incidence rates, relative survival, and 5-year conditional relative survival, stratified by sex, age, tumor type, and grade. Results A total of 1,636 incident CNS tumors with confirmed histopathology and intermediate to high-grade behavior were identified. Glioblastoma was the most frequent subtype (64.6%), followed by grade 2–3 meningiomas (18.2%) and astrocytomas (9.4%). The overall crude incidence was 8.0 per 100,000, higher in males (9.5) than females (6.6). Five-year relative survival varied substantially by tumor type and grade: glioblastoma had the poorest outcome (5.7%), while grade 2–3 ependymomas and oligodendrogliomas showed favorable prognosis (87.7% and 82.0%, respectively). Conditional 5-year survival after surviving one year remained low for glioblastoma (11.0%) but exceeded 85% for most lower-grade tumors. Conclusion Our findings underscore the prognostic relevance of tumor grade and histology, supporting the need for tailored clinical strategies, molecular diagnostics, and the development of innovative therapies for informed healthcare planning and resource allocation.Keywords
All Related Versions
This publication has 13 references indexed in Scilit:
- Epidemiology of malignant brain tumors in Genova, Italy. 1993–2017Scientific Reports, 2024
- Vorasidenib in IDH1- or IDH2-Mutant Low-Grade GliomaNew England Journal of Medicine, 2023
- Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)Neuro-Oncology, 2022
- Epidemiology of Primary Brain Tumors in the Province of Catania during the 2003–2016 PeriodNeuroepidemiology, 2021
- Primary brain tumours in adultsThe Lancet, 2018
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countriesThe Lancet, 2018
- Conditional Survival after a Diagnosis of Malignant Brain Tumour in Canada: 2000–2008Current Oncology, 2017
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- Is the incidence of brain tumors really increasing? A population-based analysis from a cancer registryJournal of Neuro-Oncology, 2011
- Epidemiology of Primary Intracranial Tumors in the Valle d'Aosta (Italy) during the 6-Year Period 1986-1991Neuroepidemiology, 1995